.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Novartis
Baxter
US Army
Fuji
Daiichi Sankyo
AstraZeneca
US Department of Justice
Mallinckrodt
Johnson and Johnson

Generated: September 26, 2017

DrugPatentWatch Database Preview

Mcneil Cons Company Profile

« Back to Dashboard

What is the competitive landscape for MCNEIL CONS, and what generic and branded alternatives to MCNEIL CONS drugs are available?

MCNEIL CONS has seven approved drugs.



Summary for Applicant: Mcneil Cons

Patents:0
Tradenames:5
Ingredients:4
NDAs:7
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mcneil Cons
BENADRYL
diphenhydramine hydrochloride
INJECTABLE;INJECTION006146-002Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Mcneil Consumer
MOTRIN
ibuprofen
TABLET;ORAL017463-004Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Mcneil Consumer
MOTRIN
ibuprofen
TABLET;ORAL017463-003Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Mcneil Cons
BENADRYL
diphenhydramine hydrochloride
INJECTABLE;INJECTION006146-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Mcneil Cons
NICOTROL
nicotine
FILM, EXTENDED RELEASE;TRANSDERMAL020536-001Jul 3, 1996DISCNNoNo► Subscribe► Subscribe► Subscribe
Mcneil Consumer
MOTRIN
ibuprofen
SUSPENSION;ORAL019842-001Sep 19, 1989DISCNYesNo► Subscribe► Subscribe► Subscribe
Mcneil Consumer
MOTRIN
ibuprofen
TABLET;ORAL017463-005May 22, 1985DISCNYesNo► Subscribe► Subscribe► Subscribe
Mcneil Cons
BENADRYL
diphenhydramine hydrochloride
CAPSULE;ORAL005845-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Mcneil Cons
SUDAFED 12 HOUR
pseudoephedrine hydrochloride
TABLET, EXTENDED RELEASE;ORAL073585-001Oct 31, 1991OTCNoYes► Subscribe► Subscribe► Subscribe
Mcneil Consumer
MOTRIN
ibuprofen
TABLET;ORAL017463-002Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Mcneil Cons

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Mcneil Cons
NICOTROL
nicotine
FILM, EXTENDED RELEASE;TRANSDERMAL020536-001Jul 3, 1996► Subscribe► Subscribe
Mcneil Consumer
MOTRIN
ibuprofen
SUSPENSION;ORAL019842-001Sep 19, 1989► Subscribe► Subscribe
Mcneil Cons
NICOTROL
nicotine
FILM, EXTENDED RELEASE;TRANSDERMAL020536-001Jul 3, 1996► Subscribe► Subscribe
Mcneil Cons
NICOTROL
nicotine
FILM, EXTENDED RELEASE;TRANSDERMAL020536-001Jul 3, 1996► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
AstraZeneca
Harvard Business School
Moodys
McKinsey
Queensland Health
Daiichi Sankyo
Mallinckrodt
Argus Health
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot